Pharmexa A/S (PHARMX.CO) and Affitech AS to Combine Operations to Create a New Antibody Therapeutics Company
3/4/2009 7:30:57 AM
More...
|
Affitech AS Acquires Pharmexa A/S (PHARMX.CO)'s Diabody Technology
10/28/2008 11:31:30 AM
More...
|
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials
5/13/2008 6:10:13 AM
More...
|
Pharmexa A/S (PHARMX.CO) Loses European Patent Appeal for Broad Claims to Telomerase-Based Cancer Vaccines
9/4/2007 11:41:45 AM
More...
|
Pharmexa A/S (PHARMX.CO) and Affitech AS Enter into an Exclusive License Agreement to Promote Diabody Technology
4/3/2007 10:55:29 AM
More...
|
Cobra BioManufacturing (CBF.L) Announces Manufacturing Agreement With Pharmexa
2/2/2007 1:43:20 PM
More...
|
Pharmexa A/S (PHARMX.CO) Files The First Phase III Application
2/1/2006 3:03:01 PM
More...
|
IDM Pharma, Inc. (IDMI) Completes Sale of Non-Core Assets To Pharmexa A/S (PHARMX.CO) For $12 Million Cash
1/3/2006 10:38:24 AM
More...
|
IDM Pharma, Inc. (IDMI) Enters Agreement To Sell Non-Core Assets To Pharmexa A/S (PHARMX.CO) For $12 Million Cash
11/28/2005 10:56:56 AM
More...
|
Pharmexa A/S (PHARMX.CO) To Acquire GemVax AS And Launch Rights Issue To Finance Two Large Phase III Trials In Pancreatic Cancer
10/19/2005 5:13:15 PM
More...
|
|